---
title: "Fuan Pharmaceutical released its first-quarter performance, with a net profit attributable to the parent company of 69.049 million yuan, a year-on-year decrease of 43.63%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237193540.md"
description: "Fuan Pharmaceutical released its Q1 2025 performance, with operating revenue of 468 million yuan, a year-on-year decrease of 42.22%; net profit attributable to the parent company of 69.049 million yuan, a year-on-year decrease of 43.63%; net profit after deducting non-recurring gains and losses of 65.6848 million yuan, a year-on-year decrease of 43.80%; basic earnings per share of 0.06 yuan/share"
datetime: "2025-04-23T13:28:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237193540.md)
  - [en](https://longbridge.com/en/news/237193540.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237193540.md)
generator: "portal-rs"
---

# Fuan Pharmaceutical released its first-quarter performance, with a net profit attributable to the parent company of 69.049 million yuan, a year-on-year decrease of 43.63%

According to the Zhitong Finance APP, Fuan Pharmaceutical (300194.SZ) released its first-quarter report for 2025. The company's operating revenue for the first quarter of 2025 was 468 million yuan, a year-on-year decrease of 42.22%; the net profit attributable to shareholders of the listed company was 69.049 million yuan, a year-on-year decrease of 43.63%; the net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 65.6848 million yuan, a year-on-year decrease of 43.80%; the basic earnings per share was 0.06 yuan/share

### Related Stocks

- [300194.CN](https://longbridge.com/en/quote/300194.CN.md)

## Related News & Research

- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)
- [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md)
- [FOCUS-Green giant: How Taylor Farms became a top salad supplier before US diarrhea outbreak](https://longbridge.com/en/news/296469939.md)
- [Alpha Entrepreneurial Partners Investment TGV takes 3.03% stake in q.beyond voting rights](https://longbridge.com/en/news/296450706.md)
- [CSPC Innovation Pharmaceutical: Biopharma licensing and product launches drove record revenue and profit growth](https://longbridge.com/en/news/296129143.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**